PIGA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.514000E-02
Normal-vs-Stage2
6.982000E-01
Normal-vs-Stage3
1.367930E-02
Normal-vs-Stage4
5.384800E-01
Stage1-vs-Stage2
2.461400E-01
Stage1-vs-Stage3
2.343800E-01
Stage1-vs-Stage4
2.489600E-01
Stage2-vs-Stage3
7.003700E-02
Stage2-vs-Stage4
9.672400E-01
Stage3-vs-Stage4
6.122000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.319000E-01
Normal-vs-AfricanAmerican
2.568600E-01
Normal-vs-Asian
5.911400E-01
Caucasian-vs-AfricanAmerican
7.993200E-01
Caucasian-vs-Asian
9.700000E-01
AfricanAmerican-vs-Asian
8.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.451200E-01
Normal-vs-Female
5.639400E-01
Male-vs-Female
9.245200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.723800E-01
Normal-vs-Age(41-60Yrs)
8.298200E-01
Normal-vs-Age(61-80Yrs)
3.892000E-01
Normal-vs-Age(81-100Yrs)
3.018000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.020600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.516800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.410600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.804800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.16309999997899E-06
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.058200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.833600E-01
Normal-vs-Daily Drinker
6.019400E-01
Normal-vs-Weekly Drinker
3.168000E-01
Normal-vs-Occasional Drinker
9.303800E-01
Normal-vs-Social Drinker
6.789600E-01
Non Drinker-vs-Daily Drinker
7.631200E-01
Non Drinker-vs-Weekly Drinker
6.989400E-01
Non Drinker-vs-Occasional Drinker
2.905000E-01
Non Drinker-vs-Social Drinker
6.467000E-01
Daily Drinker-vs-Weekly Drinker
5.396000E-01
Daily Drinker-vs-Occasional Drinker
4.708400E-01
Daily Drinker-vs-Social Drinker
8.614400E-01
Weekly Drinker-vs-Occasional Drinker
2.343000E-01
Weekly Drinker-vs-Social Drinker
4.605400E-01
Occasional Drinker-vs-Social Drinker
6.234200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.963620E-01
Normal-vs-Grade 2
6.130300E-02
Normal-vs-Grade 3
4.224400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.718900E-03
Grade 1-vs-Grade 3
6.179400E-03
Grade 1-vs-Grade 4
1.963620E-01
Grade 2-vs-Grade 3
8.200000E-01
Grade 2-vs-Grade 4
6.130300E-02
Grade 3-vs-Grade 4
4.224400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.566400E-01
Normal-vs-NonDiabetic
7.340800E-01
Diabetic-vs-NonDiabetic
5.736300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.215600E-01
Normal-vs-NoPancreatitis
5.938200E-01
Pancreatitis-vs-NoPancreatitis
6.619000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.981000E-01
Normal-vs-N1
7.358400E-01
N0-vs-N1
5.940000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.269600E-01
Normal-vs-TP53-NonMutant
3.919700E-03
TP53-Mutant-vs-TP53-NonMutant
4.437300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
